Advanced Heart Failure and Transplant Cardiology · Sacramento, CA
NPI
1194840694
Since 2007
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3939 J St Ste 230
Sacramento, CA, 95819
Phone (916) 736-2323
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
1,598 services
Medicare patients, 2024
410
Average age 75
Drug cost, 2024
$5.0M
5,665 prescriptions
Company payments, 2025
$80K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Munir S Janmohamed was code 99233 (hospital e&m - subsequent), 353 times for 75 patients. In total Munir S Janmohamed billed 1,598 services in 21 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 353 | 75 | $100.54 | $35K |
| 99214 Office E&M - Established | Office | 304 | 166 | $103.17 | $31K |
| 99214 Office E&M - Established | Facility | 181 | 140 | $80.20 | $15K |
| 99291 Critical Care E&M | Facility | 137 | 17 | $178.34 | $24K |
| 93264 External Electrocardiographic Monitoring | Facility | 113 | 21 | $27.67 | $3,127 |
| 93306 Echocardiography (TTE/TEE) | Office | 94 | 91 | $170.92 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 19 | $67.59 | $4,326 |
| 99205 Office E&M - New | Facility | 52 | 52 | $152.97 | $7,954 |
| 99222 Hospital E&M - Initial | Facility | 48 | 43 | $108.64 | $5,215 |
| 99213 Office E&M - Established | Office | 37 | 29 | $70.22 | $2,598 |
| 99205 Office E&M - New | Office | 36 | 36 | $189.67 | $6,828 |
| 99223 Hospital E&M - Initial | Facility | 19 | 18 | $147.94 | $2,811 |
| 99204 Office E&M - New | Office | 13 | 13 | $112.82 | $1,467 |
By year: 2022 $113K for 1,187 services; 2023 $127K for 1,290 services; 2024 $162K for 1,598 services.
Medicare prescription drug claims, 2024
In 2024, the drug Munir S Janmohamed prescribed most often to Medicare patients was Spironolactone, with 839 prescriptions and refills. In total Munir S Janmohamed wrote 5,665 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 839 | 1,982 | 239 | $8,246 |
| Entresto Sacubitril/Valsartan | 808 | 1,536 | 200 | $989K |
| Jardiance Empagliflozin | 538 | 957 | 133 | $536K |
| Farxiga Dapagliflozin Propanediol | 485 | 1,019 | 129 | $556K |
| Metoprolol Succinate Generic | 399 | 915 | 112 | $5,378 |
| Carvedilol Generic | 315 | 776 | 90 | $3,451 |
| Atorvastatin Calcium Generic | 273 | 712 | 81 | $2,748 |
| Furosemide Generic | 208 | 457 | 75 | $1,225 |
| Bumetanide Generic | 191 | 409 | 61 | $9,675 |
| Losartan Potassium Generic | 116 | 248 | 39 | $883 |
| Eliquis Apixaban | 111 | 246 | 34 | $139K |
| Warfarin Sodium Generic | 106 | 248 | 18 | $1,361 |
| Torsemide Generic | 99 | 222 | 30 | $1,381 |
| Eplerenone Generic | 72 | 125 | 14 | $3,604 |
| Xarelto Rivaroxaban | 70 | 136 | 16 | $73K |
Brand drugs: - claims; generic drugs: 3,307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Munir S Janmohamed $80K ($80K in general payments such as food, travel and fees) from 15 companies. The largest payer was BridgeBio Pharma, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 15 | $25K |
| Actelion Pharmaceuticals US, Inc. JNJ | 26 | $21K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 22 | $16K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $8,419 |
| CVRx, Inc. CVRX | 11 | $5,353 |
| Pfizer Inc. PFE | 2 | $1,725 |
| Lilly USA, LLC LLY | 1 | $1,210 |
| Abbott Laboratories ABT | 20 | $920 |
| Merck Sharp & Dohme LLC MRK | 4 | $292 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $189 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.